Delivery Order SPE2DB20D3505-SPE2DB24FU5S5

Award Date 7/5/24
Potential Completion Date 7/8/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,634.32, is for the delivery of TRINTELLIX 20 MG TABLET 30S, a specialty medication. The contract has a fixed-price type and an ultimate completion date of October 22, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRINTELLIX 20 MG TABLET 30S, a specialty medication. The contract has a firm fixed price of $1,341.21 and a completion date of December 9, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,074.70, is for the delivery of TRINTELLIX 20 MG TABLET 30S, a brand-name pharmaceutical product. The contract type is Firm Fixed Price, and the ultimate completion date is October 25, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TRINTELLIX 20 MG tablets. The contract has a ceiling value of $2,876.55 and a completion date of July 28, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 4560484099 TRINTELLIX 20 MG TABLET 30S, a specialty medication. The total ceiling value of the contract is $2,534.63, with an ultimate completion date of April 5, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TRINTELLIX 5 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,821.85 and is a Firm Fixed Price Delivery Order that runs through October 23, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,023.69, is for the delivery of TRINTELLIX 10 MG TABLET 30S, a prescription medication. The contract has a firm fixed-price pricing type and an ultimate completion date of January 12, 2023. This award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,124.37, is for the delivery of TRINTELLIX 20 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of July 6, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide TRINTELLIX 20 MG TABLET 30S, a pharmaceutical product, with a potential value of $1,365.27 and a period of performance through January 29, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRINTELLIX 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,325.52 and a period of performance through March 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FU5S5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRINTELLIX 20 MG TABLET 30S, a prescription medication. The total ceiling value of the contract is $2,390.23, and it has a period of performance through July 8, 2024.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. As a leading pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products and medications.

Generated 10/4/24, 9:20 AM